share_log

康华生物(300841.SZ):ACYW135群脑膜炎球菌多糖疫苗原液车间等已完成建设

chengdu kanghua biological products (300841.SZ): The construction of the raw material workshop for ACYW135 meningococcal polysaccharide vaccine has been completed.

Gelonghui Finance ·  Nov 5, 2024 23:58

Gelonghui, November 6th: chengdu kanghua biological products (300841.SZ) stated on the investor interaction platform that the company has completed the construction of the ACYW135 group meningococcal polysaccharide vaccine raw liquid workshop and the "Kanghua biological vaccine production expansion project". They are currently in the supplementary application stage for pharmaceutical production permits, and production can begin after obtaining the production permit.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment